人力资源管理准确性和局限性作为一种物种类型工具,用于Leishmania寄生虫
Camila Patricio Braga Filgueira1, Daniela Pitta-Pereira2, Lilian Motta Cantanhêde1,3,4
1Leishmaniasis Research Laboratory, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-360, Brazil.
International journal of molecular sciences
|October 14, 2023
概括
高分辨率化分析 (HRM) 能够有效地识别培养寄生虫中的Leishmania物种. 然而,使用HSP70-HRM协议的临床样本的准确性取决于寄生虫负载,需要结合量化和类型化方法.
科学领域:
- 分子生物学分子生物学
- 寄生虫学的寄生虫学
- 传染性疾病 传染性疾病
背景情况:
- 高分辨率化分析 (HRM) 是用于检测和识别Leishmania物种的公认方法.
- HSP70基因是基于HRM的Leishmania*识别的潜在目标.
- 准确的Leishmania物种识别对于诊断,治疗和流行病学监测至关重要.
研究的目的:
- 评估HSP70-HRM协议的灵敏度,特异性和准确性,用于*Leishmania*物种识别.
- 评估HSP70-HRM作为临床样本诊断工具的实用性.
- 确定HSP70-HRM对实验室研究和参考服务的有效性.
主要方法:
- 从培养的Leishmania寄生虫和临床样本中提取DNA.
- 聚合酶链反应 (PCR) 对HSP70基因的放大.
- 高分辨率化 (HRM) 分析用于物种识别.
- 与现有的Leishmania量化方法进行比较.
主要成果:
- HSP70-HRM协议使用培养寄生虫的DNA进行了物种类型的高准确性.
- 临床样本的准确性被发现取决于寄生虫负载.
- 该研究强调了除了物种识别外,还需要对寄生虫负荷进行确定.
结论:
- 在实验室环境中,HSP70-HRM是*Leishmania*物种类型的宝贵工具.
- 建议在使用HSP70-HRM进行临床诊断时谨慎使用,因为寄生虫负载的可变性.
- 建议将HSP70-HRM与寄生虫量化方法相结合,用于全面的临床和研究应用.
相关概念视频
Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


